Secondary Coronary Artery Vasospasm Promotes Cardiomyopathy Progression

This publication has 37 references indexed in Scilit:

• Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy
  The FASEB Journal, 2002
• Analysis of the spatial, temporal and tissue‐specific transcription of γ‐sarcoglycan gene using a transgenic mouse
  FEBS Letters, 2001
• Expression of γ-Sarcoglycan in Smooth Muscle and Its Interaction with the Smooth Muscle Sarcoglycan-Sarcospan Complex
  Published by Elsevier ,2000
• Dystrophin and utrophin: Genetic analyses of their role in skeletal muscle
  Microscopy Research and Technique, 2000
• Human ϵ‐sarcoglycan is highly related to α‐sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene¹
  FEBS Letters, 1998
• Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
  Nature, 1992
• Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice
  Journal of the American College of Cardiology, 1989
• Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy
  The American Journal of Cardiology, 1985
• Hypothesis: Is congestive cardiomyopathy caused by a hyperreactive myocardial microcirculation (Microvascular spasm)?
  The American Journal of Cardiology, 1982
• Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.
  Circulation, 1982